Camarillo-based Semtech topped analysts’ expectations on Dec. 1 with an announcement of record net sales and net income in the third quarter of its 2021-22 fiscal year. Semtech, a semiconductor company specializing in Internet of Things applications, generated sales totaling $194.9 million in the third quarter of 2021, up 27% from the same quarter a Read More →
Santa Barbara home audio company Sonos beat analysts’ expectations with its fourth-quarter earnings and also delivered record revenues for its 2021 fiscal year, but supply chain issues could spoil the first half of 2022, the company said. Sonos reported a net loss of $8.7 million in the quarter ended Sept. 30, according to results released Read More →
Goleta-based Transphorm saw revenue increase for the seventh consecutive quarter and also reported a profit for the quarter ended Sept. 30. Transphorm, a supplier of gallium nitride power conversion products, reported net income of $6 million, or 15 cents per share, compared to a net loss of $7.1 million in the same quarter a year Read More →
Net losses grew for Resonant in the third quarter of 2021, as the company announced an expanded multi-year agreement with its manufacturing partner. Resonant, which is based in both Santa Barbara and Austin, Texas, provides radio frequency filters for multiple applications, including 5G cellular devices. The company generated $400,000 in revenue for the third quarter, Read More →
Goleta-based Sientra missed analysts’ expectations when it released financial results for the third quarter of 2021 on Nov. 10, posting a net loss when accounting for certain one-time factors such as the relief of its paycheck protection program loan. Sientra, a plastic surgery device company specializing in breast implants, had net income of $28.4 million Read More →
Glass House Brands, a cannabis grower in Santa Barbara and Ventura counties and retailer and wholesaler statewide, saw both its revenue and net losses grow in the third quarter. Glass House, which has its headquarters in Long Beach but most of its operations on the Central Coast, delivered revenue of $17.2 million in the third Read More →
MannKind Corp. reported a substantial rise in revenue and a shrinking net loss in the third quarter of 2021 on Nov. 9, despite news since the quarter ended that the U.S. Food and Drug Administration will not yet approve a hypertension treatment the company is developing with United Therapeutics. MannKind, a Westlake Village-based biotechnology company Read More →